“Track Your Journey. Impact the World.” CBD consumers can now track and share their experiences through CBD+me™ Centennial, Colo. – July 11, 2019 – ValidCare today announced the launch of its consumer platform, CBD+me™. CBD+me allows consumers to track their wellness journey as they record the effects of cannabis-derived products, enabling them to […]
Join ValidCare Round Table Discussion “Why Standards Matter”
Thursday, June 20, 2019 at 2:00 PM ET Industry thought leaders will address issues related to quality and standards in canna-based product industry Centennial, Colo. – June 17, 2019 – Among the significant challenges facing the canna-based product industry is the consistency, quality and effectiveness of CBD products. As rapid growth occurs, and new businesses and […]
CBD American Shaman Joins ValidCare to Understand Impact of CBD on Wellness
Centennial, Colo. – Wednesday, March 20, 2019 – CBD American Shaman has entered into a multi-year agreement with ValidCare, LLC to understand the use and effects of its hemp-based CBD oil for consumers. CBD American Shaman is a vertically-integrated industrial hemp supplier based in Kansas City, MO, with products sold across all 50 states through an extensive […]
ValidCare Selected as Technology Platform for National Cannabis Patient Registry by CSU-Pueblo Institute of Cannabis Research
Secure patient registry will help support the call for greater real-world knowledge of medical cannabis through patient use CENTENNIAL, COLO. (PRWEB) MARCH 11, 2019 ValidCare, LLC, today announced its Platform as a Service is powering the Cannabis Patient Registry at the CSU-Pueblo Institute of Cannabis Research (CSU-P/ICR). The patient registry is now live and allows collection […]
CBD-based Product Leader Elixinol, LLC Joins ValidCare Community for Ongoing Product and Consumer Experience Insights
CBD-based Product Leader Elixinol, LLC Joins ValidCare Community for Ongoing Product and Consumer Experience Insights U.S. Health and wellness consumers will track real-time experiences related to their use of Elixinol’s broad range of CBD-based products, helping to create aggregated insights Centennial, Colo. – November 19, 2019 – Elixinol, LLC, a U.S. subsidiary of Elixinol Global (EXL), […]
Using Insights from Patient and Health Consumer Experiences to Power Canna-based Product Research and Development
Product suppliers and developers, researchers, clinicians, patients and health consumers are at the intersection of rapidly developing cannabinoid products, new treatment options and a deficiency of real-world data. How can we derive greater insights and understanding within this burgeoning market to establish a knowledge-based foundation that can benefit all participants? Executive Summary Today, patients and […]
ValidCare Joins U.S. Hemp Roundtable
Membership in coalition will support alignment and shared interest with rapidly growing, hemp-derived CBD product industry Centennial, Colo. – ValidCare, LLC, today announced it has become a member of the U.S. Hemp Roundtable, an independent, non-profit organization with a membership base of several dozen hemp companies, representing every link of the product chain from seed […]
ValidCare Partners with GenCanna Global to Measure Impact and Efficacy of Hemp-based Products from Seed to Outcomes
Leading Kentucky hemp producer joins growing global community to support goal of improving results from health-focused cannabinoid- (CBD-) based products Centennial, Colo. – Monday, September 24, 2018 – GenCanna Global, Inc. has entered into a multi-year, strategic advisement and membership agreement with ValidCare, LLC, to measure the benefits of hemp-derived CBD for global consumers. GenCanna […]
ValidCare Strides into the CBD-Product Community to Provide Insights-as-a-Service
With a mission to connect, collect and inform, ValidCare will help product suppliers and developers, researchers, clinicians and consumers improve outcomes through collaborative, member-driven platform Centennial, Colo. – September 10, 2018 – ValidCare today announced it will bring together businesses, research organizations, clinicians and others working in the cannabinoid (CBD)-product community, to improve patient experiences […]